Roche Diagnostics Asia Pacific

As one of the largest providers of diagnostic services in Pakistan, Islamabad Diagnostics Centre (IDC) performs more than 7 million tests annually across 130 branches in the country. In this video, Chairman, Founder & CEO, Dr Rizwan Uppal talks about the establishment of the IDC brand, how patient-centricity is at the core of his business, and how he aims to bring healthcare closer to the people of Pakistan. https://lnkd.in/gHWtydFq

In the time it will take you to watch this video, 24 people would have lost their lives to #hepatitis. People with a history of drug use, high risk sexual behaviors and needle usage from tattoos and piercings often are at higher risk for hepatitis. Most are reluctant to get screened for the fear of being labeled as someone “who deserves it”. A WHO study found that an estimated 4.5 million premature deaths could be prevented in low- and middle-income countries by 2030 through vaccination, diagnostic tests, medicines, and education campaigns. Diagnostic screening is the first line of defense against hepatitis. A timely diagnosis provides more treatment options and prevents the escalation of hepatitis to Cirrhosis or Hepatocellular Carcinoma (HCC), which may be irreversible. We spoke to four people who have bravely shared their diagnosis, while millions continue to live in silence. Everyone deserves to get tested, let silence not come in the way of getting screened. http://spkl.io/60424CqK2 #EmpowerPatients #LiverDisease #BreakingBarriers #Hepatitis #HCV

The majority of the world’s #hepatitis cases are found in the Asia Pacific region, with about 94.6 million infected individuals. The reality is many countries in the region are far from reaching the World Health Organization’s Hepatitis elimination goals. At a recent event, @Dr Saeed Hamid, Professor and Chair of the Department of Medicine at Aga Khan University, spoke about the need to declare Hepatitis elimination as an emergency target in high-burden countries in the Asia Pacific region, where the battle for global elimination will be won or lost. To learn more, watch the full panel discussion here: http://spkl.io/60454CqJJ #EmpowerPatients #LiverDisease #BreakingBarriers #Hepatitis #HCV

Did you know that chronic hepatitis poses a significant risk for liver cancer? Globally, there are over 300 million people suffering from viral hepatitis. Many times, individuals do not get diagnosed and treated on time because of fear and a lack of access to necessary healthcare. The fourteenth volume of Diagram dives deeper into stories all over APAC that discuss the importance of liver health, how it deserves more attention and how it can be managed. Learn more here: http://spkl.io/60454CisB #EmpowerPatients #LiverDisease #BreakingBarriers #Hepatitis #HCV

Did you know that clinical outcomes for cancer in APAC has an estimated mortality-to-incidence ratio (MIR) of 0.52 as compared to 0.32 in the West? This is why innovative technologies like Next-Generation Sequencing (NGS) are a potential game-changer in cancer care. This latest paper written by Asia Pacific Medical Technology Association (APACMed), explores NGS’s role in personalised treatment, its real-world impact on patient outcomes, and a value assessment framework to improve access. Read about this in the whitepaper here: http://spkl.io/60434CzE5 #Roche #APACMed #NGS #healthcare

At Roche, our passion for science extends to supporting the next generation. Children's Walk, an employee-driven initiative is our largest philanthropic event, raising millions for children's education around the world. We believe that children in need everywhere deserve a helping hand towards a brighter future. Employees fundraise to support projects through the legally independent global charity Roche Employee Action and Charity Trust (Re&Act), as well as local projects in over 75 countries where we operate and beyond. Employees fundraise for global children’s projects relating to education, nutrition, primary healthcare and social development. Donations are company-matched and since the first company Walk in 2003, more than 315,000 Roche employees have raised over CHF 23 million in donations for children’s projects globally. Last Friday, our colleagues in Singapore gathered together to walk 5km to commemorate Children's Walk as we raise funds for Club Rainbow (Singapore), a non-profit organisation that provides support for Children suffering from terminal illnesses, and their families. Learn more about the Walk and its beneficiaries, and join us in making a lasting impact: https://lnkd.in/g3rWRnn7 #RocheChildrensWalk #RochePhilanthropy #Education #Healthcare

What would the future of Pathology look like? Currently, conventional workflows present challenges including resource shortage, physical strain, and increasing diagnosis complexity. Over 25 Pathology professionals from 7 key markets in Asia Pacific gathered in Seoul last month for the inaugural 'Roche Digital Pathology Insight Symposium', to discuss how Pathology can go beyond the Light Microscope to an end-to-end suite of digital solutions. Attendees also participated in workshops designed to map out their Digital Pathology (DP) adoption journey and readiness, while exchanging ideas on overcoming barriers to adoption. Key takeaways included: - DP addressed challenges through improvements such as reduced turnaround time, labeling errors, and enabling remote multidisciplinary collaborations. - Adoption challenges, such as pushback from management, were discussed. Attendees exchanged ideas to build a robust business case, such as highlighting that DP leads to efficient use of manpower, workload, and infrastructure. - The potential of AI-powered algorithms to transform DP with increasingly precise diagnoses was highlighted. Roche would like to thank all speakers, participants, and our reference site GC Labs for for their invaluable contributions during the Symposium. #digitalpathology #digitalhealth #diagnostics

At EUROGIN 2024, Prof Dietmar Schmidt of MVZ Histology, Cytology and Molecular Diagnostics discusses the use of 16/Ki67 dual staining biomarkers as a predictor of risk for HPV-positive patients; its advantages over other testing methods in triage; and the updated Enduring Consensus Cervical Cancer Screening and Management Guidelines. Watch now on Lab Insights. https://lnkd.in/g6NEehZe

In Part 2 of this Q&A with Awanui Group CEO Anoop Singh, we hear more about the changes that his organisation underwent over the past few years, what it meant for the organisation, and the lessons learned as he navigates this change. Watch now on Lab Insights. https://lnkd.in/gASTRQ8h

In Part 1 of this Q&A with Anoop Singh, CEO of Awanui Group, we hear how his organisation partners with IVD suppliers, community groups, governmental entities and other key stakeholders to provide services across the care continuum in New Zealand. Watch now on Lab Insights. https://lnkd.in/gQVRFMch